183 related articles for article (PubMed ID: 35613689)
1. ESR1 inhibits ionizing radiation-induced ferroptosis in breast cancer cells via the NEDD4L/CD71 pathway.
Liu L; Zhang C; Qu S; Liu R; Chen H; Liang Z; Tian Z; Li L; Ma S; Liu X
Arch Biochem Biophys; 2022 Aug; 725():109299. PubMed ID: 35613689
[TBL] [Abstract][Full Text] [Related]
2. The Dual Regulation Effects of ESR1/NEDD4L on SLC7A11 in Breast Cancer Under Ionizing Radiation.
Liu R; Liu L; Bian Y; Zhang S; Wang Y; Chen H; Jiang X; Li G; Chen Q; Xue C; Li M; Liu L; Liu X; Ma S
Front Cell Dev Biol; 2021; 9():772380. PubMed ID: 35252218
[TBL] [Abstract][Full Text] [Related]
3. NEDD4L-mediated LTF protein degradation limits ferroptosis.
Wang Y; Liu Y; Liu J; Kang R; Tang D
Biochem Biophys Res Commun; 2020 Oct; 531(4):581-587. PubMed ID: 32811647
[TBL] [Abstract][Full Text] [Related]
4. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen.
Habashy HO; Powe DG; Staka CM; Rakha EA; Ball G; Green AR; Aleskandarany M; Paish EC; Douglas Macmillan R; Nicholson RI; Ellis IO; Gee JM
Breast Cancer Res Treat; 2010 Jan; 119(2):283-93. PubMed ID: 19238537
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of ZBTB7A inhibits cell proliferation of breast cancer through regulating the ubiquitination of estrogen receptor alpha.
Xiao X; Shen Y; Yin L; He J; Ni X; Luo G; Chen X; Zhu W; Zhong J; Liu J; Peng X; Zu X
Life Sci; 2019 Dec; 239():117042. PubMed ID: 31715186
[TBL] [Abstract][Full Text] [Related]
6. METTL3 regulates TFRC ubiquitination and ferroptosis through stabilizing NEDD4L mRNA to impact stroke.
Su W; Yu X; Wang S; Wang X; Dai Z; Li Y
Cell Biol Toxicol; 2024 Feb; 40(1):8. PubMed ID: 38302612
[TBL] [Abstract][Full Text] [Related]
7. Sulfasalazine‑induced ferroptosis in breast cancer cells is reduced by the inhibitory effect of estrogen receptor on the transferrin receptor.
Yu H; Yang C; Jian L; Guo S; Chen R; Li K; Qu F; Tao K; Fu Y; Luo F; Liu S
Oncol Rep; 2019 Aug; 42(2):826-838. PubMed ID: 31173262
[TBL] [Abstract][Full Text] [Related]
8. Multimodal Assessment of Estrogen Receptor mRNA Profiles to Quantify Estrogen Pathway Activity in Breast Tumors.
Muthukaruppan A; Lasham A; Woad KJ; Black MA; Blenkiron C; Miller LD; Harris G; McCarthy N; Findlay MP; Shelling AN; Print CG
Clin Breast Cancer; 2017 Apr; 17(2):139-153. PubMed ID: 27756582
[TBL] [Abstract][Full Text] [Related]
9. NEDD4L facilitates granulosa cell ferroptosis by promoting GPX4 ubiquitination and degradation.
Tang H; Jiang X; Hua Y; Li H; Zhu C; Hao X; Yi M; Li L
Endocr Connect; 2023 Apr; 12(4):. PubMed ID: 36662677
[TBL] [Abstract][Full Text] [Related]
10. Neo-tanshinlactone selectively inhibits the proliferation of estrogen receptor positive breast cancer cells through transcriptional down-regulation of estrogen receptor alpha.
Lin W; Huang J; Liao X; Yuan Z; Feng S; Xie Y; Ma W
Pharmacol Res; 2016 Sep; 111():849-858. PubMed ID: 27491559
[TBL] [Abstract][Full Text] [Related]
11. NEDD4L downregulates autophagy and cell growth by modulating ULK1 and a glutamine transporter.
Lee DE; Yoo JE; Kim J; Kim S; Kim S; Lee H; Cheong H
Cell Death Dis; 2020 Jan; 11(1):38. PubMed ID: 31959741
[TBL] [Abstract][Full Text] [Related]
12. Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer.
Kang MH; Jeong KJ; Kim WY; Lee HJ; Gong G; Suh N; Győrffy B; Kim S; Jeong SY; Mills GB; Park YY
Oncogene; 2017 Mar; 36(12):1745-1752. PubMed ID: 27593929
[TBL] [Abstract][Full Text] [Related]
13. Mutation site and context dependent effects of ESR1 mutation in genome-edited breast cancer cell models.
Bahreini A; Li Z; Wang P; Levine KM; Tasdemir N; Cao L; Weir HM; Puhalla SL; Davidson NE; Stern AM; Chu D; Park BH; Lee AV; Oesterreich S
Breast Cancer Res; 2017 May; 19(1):60. PubMed ID: 28535794
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of IRS1 Enhances IGF1 Response in Y537S and D538G ESR1 Mutant Breast Cancer Cells.
Li Z; Levine KM; Bahreini A; Wang P; Chu D; Park BH; Oesterreich S; Lee AV
Endocrinology; 2018 Jan; 159(1):285-296. PubMed ID: 29029116
[TBL] [Abstract][Full Text] [Related]
15. Paeoniflorin Regulates NEDD4L/STAT3 Pathway to Induce Ferroptosis in Human Glioma Cells.
Nie XH; Qiu S; Xing Y; Xu J; Lu B; Zhao SF; Li YT; Su ZZ
J Oncol; 2022; 2022():6093216. PubMed ID: 36618071
[TBL] [Abstract][Full Text] [Related]
16.
Mitobe Y; Ikeda K; Suzuki T; Takagi K; Kawabata H; Horie-Inoue K; Inoue S
Mol Cell Biol; 2019 Dec; 39(23):. PubMed ID: 31501276
[TBL] [Abstract][Full Text] [Related]
17. The GPER1/SPOP axis mediates ubiquitination-dependent degradation of ERα to inhibit the growth of breast cancer induced by oestrogen.
Zhang N; Sun P; Xu Y; Li H; Liu H; Wang L; Cao Y; Zhou K; TinghuaiWang
Cancer Lett; 2021 Feb; 498():54-69. PubMed ID: 33069770
[TBL] [Abstract][Full Text] [Related]
18. Targeted degradation of activating estrogen receptor α ligand-binding domain mutations in human breast cancer.
Gonzalez TL; Hancock M; Sun S; Gersch CL; Larios JM; David W; Hu J; Hayes DF; Wang S; Rae JM
Breast Cancer Res Treat; 2020 Apr; 180(3):611-622. PubMed ID: 32067153
[TBL] [Abstract][Full Text] [Related]
19. E3 ligase Nedd4l promotes antiviral innate immunity by catalyzing K29-linked cysteine ubiquitination of TRAF3.
Gao P; Ma X; Yuan M; Yi Y; Liu G; Wen M; Jiang W; Ji R; Zhu L; Tang Z; Yu Q; Xu J; Yang R; Xia S; Yang M; Pan J; Yuan H; An H
Nat Commun; 2021 Feb; 12(1):1194. PubMed ID: 33608556
[TBL] [Abstract][Full Text] [Related]
20. Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer.
Li Y; Li Y; Wedrén S; Li G; Charn TH; Desai KV; Bonnard C; Czene K; Humphreys K; Darabi H; Einarsdóttir K; Heikkinen T; Aittomäki K; Blomqvist C; Chia KS; Nevanlinna H; Hall P; Liu ET; Liu J
Breast Cancer Res; 2011 Jan; 13(1):R10. PubMed ID: 21269472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
